Kringle Pharma, Inc. Statistics
Want to see JP:4884 full AI Analyst Report?
Kringle Pharma, Inc. (4884) Stock Statistics & Valuation Metrics
Total Valuation
Kringle Pharma, Inc. has a market cap or net worth of JPY 4.46B. The enterprise value is JPY 1.08B.
- Market Cap
- JPY 4.46B
- Enterprise Value
- JPY 1.08B
Share Statistics
Kringle Pharma, Inc. has 8,593,200 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 8,593,200
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Kringle Pharma, Inc.’s return on equity (ROE) is -0.70 and return on invested capital (ROIC) is -45.26%.
- Return on Equity (ROE)
- -0.70
- Return on Assets (ROA)
- -0.41
- Return on Invested Capital (ROIC)
- -45.26%
- Return on Capital Employed (ROCE)
- -0.45
- Revenue Per Employee
- 26.05M
- Profits Per Employee
- -47.86M
- Employee Count
- 17
- Asset Turnover
- 0.22
- Inventory Turnover
- 0.39
Valuation Ratios
The current PE Ratio of Kringle Pharma, Inc. is -5.26. Kringle Pharma, Inc.’s PEG ratio is -0.23.
- PE Ratio
- -5.26
- PS Ratio
- 10.82
- PB Ratio
- 4.16
- Price to FCF
- 0.00
- Price to Operating Cash Flow
- -6.43
- PEG Ratio
- -0.23
Income Statement
In the last 12 months, Kringle Pharma, Inc. had revenue of 442.92M and earned -813.64M in profits. Earnings per share was -105.32.
- Revenue
- 442.92M
- Gross Profit
- 372.54M
- Operating Income
- -813.45M
- Pretax Income
- -811.87M
- Net Income
- -813.64M
- EBITDA
- -813.45M
- Earnings Per Share (EPS)
- -105.32
Cash Flow
In the last 12 months, operating cash flow was -755.78M and capital expenditures 755.78M, giving a free cash flow of 0 billion.
- Operating Cash Flow
- -755.78M
- Free Cash Flow
- 0
- Free Cash Flow per Share
- 0.00
Dividends & Yields
Kringle Pharma, Inc. pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 0.00%
- Earnings Yield
- -16.76%
Stock Price Statistics
- Beta
- 0.59
- 52-Week Price Change
- 29.53%
- 50-Day Moving Average
- 533.02
- 200-Day Moving Average
- 427.95
- Relative Strength Index (RSI)
- 52.30
- Average Volume (3m)
- 282.72K
Important Dates
Kringle Pharma, Inc. upcoming earnings date is Feb 05, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 11, 2026
- Next Earnings Date
- Feb 05, 2027
- Ex-Dividend Date
- ―
Financial Position
Kringle Pharma, Inc. as a current ratio of 10.77, with Debt / Equity ratio of 0.00%
- Current Ratio
- 10.77
- Quick Ratio
- 9.77
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 2.07
- Interest Coverage Ratio
- 0.00
Taxes
In the past 12 months, Kringle Pharma, Inc. has paid 1.77M in taxes.
- Income Tax
- 1.77M
- Effective Tax Rate
- -0.00
Enterprise Valuation
Kringle Pharma, Inc. EV to EBITDA ratio is -3.81, with an EV/FCF ratio of 0.00.
- EV to Sales
- 7.02
- EV to EBITDA
- -3.81
- EV to Free Cash Flow
- 0.00
- EV to Operating Cash Flow
- -4.11
Balance Sheet
Kringle Pharma, Inc. has JPY 1.70B in cash and marketable securities with JPY 0.00 in debt, giving a net cash position of JPY 1.70B billion.
- Cash & Marketable Securities
- JPY 1.70B
- Total Debt
- JPY 0.00
- Net Cash
- JPY 1.70B
- Net Cash Per Share
- JPY 197.31
- Tangible Book Value Per Share
- JPY 149.38
Margins
Gross margin is 79.88%, with operating margin of -183.96%, and net profit margin of -184.00%.
- Gross Margin
- 79.88%
- Operating Margin
- -183.96%
- Pretax Margin
- -183.60%
- Net Profit Margin
- -184.00%
- EBITDA Margin
- -184.32%
- EBIT Margin
- -184.32%
Analyst Forecast
The average price target for Kringle Pharma, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 513.34%
- EPS Growth Forecast
- 20.92%
Scores
- Smart Score
- ―
- AI Score
- 47
